Click Therapeutics

Overview

Click Therapeutics is a digital therapeutics company founded in 2012 by David Benshoof Klein, who serves as CEO[4]. Headquartered at 80 White Street in New York[2], the company develops software-based therapeutics evaluated through clinical trials and commercial partnerships[1]. Click Therapeutics states that it develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs, working with pharmaceutical partners and payers[3].

The company's pipeline includes CT-152 (Rejoyn) for major depressive disorder, developed in collaboration with Otsuka Pharmaceutical[7], CT-132 for episodic migraine marked FDA Authorized, CT-155 for schizophrenia in Phase 3, CT-156 for schizophrenia in Phase 2, and CT-102 for opioid use disorder in Phase 2[5]. Earlier-stage programs span CT-133 for multiple sclerosis, CT-171 for atopic dermatitis, CT-181 for obesity, CT-191 in oncology, CT-141 for insomnia, and CT-111 for acute coronary syndrome[6]. The company maintains offices in New York, Boston, Miami, and Raleigh[10] and lists H.I.G., Accelmed, and Sanofi Ventures among its investors[8].

Headquarters at 80 White Street, 3rd floor, New York, New York 10013 [2]

Click Therapeutics' pipeline lists CT-152 (Rejoyn) for major depressive disorder, CT-132 for episodic migraine marked FDA Authorized, CT-155 for schizophrenia in Phase 3, CT-156 for schizophrenia in Phase 2 and CT-102 for opioid use disorder in Phase 2. [5]

Click Therapeutics' earlier-stage programs include CT-133 for multiple sclerosis, CT-171 for atopic dermatitis, CT-181 for obesity, CT-191 in oncology, CT-141 for insomnia and CT-111 for acute coronary syndrome. [6]

Click Therapeutics' New York office is at 80 White Street, 3rd floor, New York, New York 10013. [9]

Partnerships

Click Therapeutics collaborated with Otsuka Pharmaceutical on CT-152 (Rejoyn) for major depressive disorder. [7]

Growth & traction

Click Therapeutics lists four offices: New York (80 White Street), Boston (855 Boylston Street), Miami (1111 Brickell Avenue) and Raleigh (555 Fayetteville Street). [10]